Skip to main content
. 2020 Sep 28;22:70. doi: 10.1186/s12968-020-00663-7

Table 3.

CMR derived parameters in the three groups

Healthy Controls CA-LVEFp CA-LVEFd P
LVEDV (mL/m2) 70 ± 13 72 ± 14 83 ± 12 0.001
LVESV (mL/m2) 21 ± 6 26 ± 6 38 ± 6 <  0.001
LVEF (%) 69 ± 6 65 ± 5 54 ± 3 <  0.001
LVM (g/m2) 68 ± 10 79 ± 13 84 ± 12 <  0.001
RWM (g/mL) 0.99 ± 0.15 1.10 ± 0.23 1.04 ± 0.19 0.003
LVH (n, % of subjects with LVH) 0, 0 17, 28 11, 34 0.001
LGE (n, % of subjects with LGE) 0, 0 18, 30 10, 33 0.001
LGE (gr) 0 0.79 ± 0.18 0.89 ± 0.23 0.089
LGE (% of LV myocardium) 0 0.54 ± 0.13 0.55 ± 0.13 0.265
RVEDV (mL/m2) 73 ± 13 79 ± 15 87 ± 12 0.004
RVESV (mL/m2) 28 ± 7 34 ± 9 41 ± 7 <  0.001
RVEF (%) 62 ± 6 58 ± 5 52 ± 4 <  0.001

LV left ventricle, EDV end-diastolic volume, ESV end-systolic volume, EF ejection fraction, LVM left ventricular mass, RWM relative wall mass, LVH left ventricular hypertrophy, RV right ventricle